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1030-l Relationship of Severe Microvascular Injury as 
Assessed Based on Phasic Coronary Flow Patterns 
With Complications and In-Hospital Survival After Acute 
Myocardial Infarction 
&&i Yamamurg, Takashi Akasaka, Tsutomu Takagi, Koichi Tamita, Kenji Yamabe, 
Minako Katayama, Kunihiko Nagai, Tomoko Tani, Kazuaki Tanabe, Shigefumi Morioka. 
KoLw General Hospital, Kobe, Japan, Kawasaki Medical School, Kurashiki, Japan. 
Background: Previous studies have shown that angiographic contrast velocity, as defined 
by the Thrombolysis in Myocardial Infarction (TIMI) criteria, can differentiate different Iev- 
els of antegrade flow, with different prognostic implications. Our recent study has identi- 
fied, using a Doppler guidewire, phasic coronary flow patterns (CFP) that differentiate 
patients with residual flow-limiting obstructions from those with severe microvascular 
injury, both of which lead to persistent slow reflow (TIMI 2 flow). However, the relation 
between severe microvascular injury and clinical outcomes has not yet been investi- 
gated. The aim of this study was to examine whether CFP may predict complications and 
in-hospital survival after acute myocardial infarction (AMI). 
Methods: The study population consisted of 150 consecutive patients with a first anterior 
AMI successfully treated with percutaneous coronary intervention (PCI). We examined 
the CFP immediately after PCI using a Doppler guidewire. In accordance with previous 
reports on CFP, we defined severe microvascular injury as the diastolic deceleration time 
(DDT) <= 600 ms and the presence of systolic flow reversal. From CFP, patients were 
divided into two groups: those without severe microvascular injury (n=lOl; Group 1) and 
those with severe microvascular injury (n=49; Group 2). 
Results: Percardial effusion and cardiac rupture were observed more frequently in Group 
2 than in Group 1 (55% vs 9%, ~~0.01; 16% vs O%, p<O.Ol, respectively). All patients 
with cardiac rupture were observed in Group 2, two patients of blowout-type, one patient 
of ventricular septal defect, one patient of subepicardial aneurysm, and five patients of 
oozing rupture. Congestive heart failure (CHF) was observed more frequently in Group 2 
than in Group 1 (51% vs 16%. pcO.01). in-hospital cardiac mortality rate was significantly 
higher in Group 2 than in Group 1 (16% vs O%, pcO.01). Eight patients in Group 2 died, 
five patients due to CHF and three patients because of acute cardiac rupture. 
Conclusions: These data suggest that the assessment of CFP with severe microvascular 
injurY provides an accurate means to predict complications and in-hospital survival after 
AMI. 
1030-2 Limitation of Intravascular Ultrasound in Determining 
Artery Size: Role of Distension Pressure 
vR. Khaled M. Ziada, Debabrata Mukherjee, Steven E. Nissen, E. M. 
Tuzcu. Universify of Washington, Seattle, Washington. The Cleveland Clinic Foundation, 
Cleveland, Ohio. 
Background: Intravascular ultrasound (IVUS) allows in viva investigation of coronary 
arterial remodeling. Clinically available IVUS catheters are approximately 1 mm in diam- 
eter and may impede flow in an arterial segment beyond a significant stenosis. The 
effects of flow impediment and subsequent decrease in distension pressure on distal 
vessel size are not well characterized. We sought to determine whether vessel and 
lumen size distal to a significant lesion are any different after the lesion is treated with 
percutaneous intervention. Methods: We analyzed 57 patients who had IVUS examina- 
tion performed before and after percutaneous intewention using a motorized pullback. 
Measurements were performed at each 1 mm distance from most distal to proximal end. 
We compared the vessel volume and plaque volume at sites distal and proximal to the 
treated segment, before and after percutaneous intervention. Results: Measurements of 
vessel area and plaque volume were made proximal and distal to significant stenosis 
(6&B% area stenosis). There was significant increase in the lumen and vessel area of 
the distal segments. There was no change in the plaque area. Unchanged proximal ves- 
sel, lumen and plaque area measurements indicate unaltered vasomotor tone pre and 
post intervention. (Table) 
Segment Preintervention Postintervention P 
Distal Lumen area 6.78i2.31 7.76i2.41 <0.0001 
Distal Vessel Area 10.65i4.22 11.9Oi3.99 <O.OOOl 
Distal Plaque Area 4.19i2.70 4.16zt2.96 0.94 
Proximal Lumen Area 9.44zt3.40 9.66k3.40 0.23 
Proximal Vessel Area 16.37zt4.55 16.8615.03 0.10 
Proximal Plaque Area 6.67i2.36 7.14ti.66 0.12 
Conclusions: Intravascular ultrasound underestimates vessel and lumen area distal to 
significant luminal stenosis. This important variable should be taken into account when 
interpreting data on arterial remodeling. 
1030-3 lntracoronary Ultrasound of Angiographlcally 
Ambiguous Left Main Coronary Artery Stenoses; Safety 
and Effect on Further Clinical Decision Making 
K&&x&l& Rudolf Schiele. Gunnar Taubett. Karl-Heinz Seidl, Caroline Bergmeier, 
Jochen Senges. Ralf Zahn. Herzzentrum Ludwfgshafen, Ludwigshafen, Germany 
Background: In clinical practice indications for intracoronary ultrasound (ICUS) have 
declined in the recent years. ICUS for angiographic uncertain results of the left main car- 
onary artery (LMCA) is one of the more common indications. There is few data about the 
safety and effect of ICUS on further clinical decision in those cases. 
Methods: From September 1996.July 2001 55 (25%) ICUS of the LMCA out of a total of 
221 ICUS were consecutiveley registered. 
&su/ts: Patients characterization: mean age 61 years, male sex 37 (67%). 40 (73%) 
stable and 15 (27%) unstable angina pectoris, known CAD 20 (36%), history of CABG 10 
(16%), history of PTCA 19 (35%). ICUS of the LMCA was performed due to 39 (71%) 
angiographically ambiguous ostial lesions (group 7) and 16 (29%) presumed distal 
lesions (group 2). ICUS was feasable in 100%. There were no major ICUS-related com- 
plications: 4 (7%) patients had asymptomatic. 1 (2%) had temporary symptomatic coro- 
nary spasms. 
LMCA-stenosis graded by ICUS: Group 1 (n=39/55) Group 2 (n=l6/55) 
Mild (< 40%) 6 (21%) 13 (61%) 
Moderate (40-70%) 19 (49%) 3 (19%) 
Severe (>70%) 12 (30%) 0 
Only due to ICUS findings 12 (22%) CABG were palformed because of severe LMCA- 
stenoses, 17 (31%) presumed high-graded LMCA-stenoses could be excluded, so that 
an intervention was unnecessary, ICUS confirmed 26 (47%) angiographic results and did 
not change the further clinical decision. 
Conclusion: ICUS of the LMCA in cases with ambiguous angiographic results is feas- 
able and save, if performed by a skilled examiner. With 25% of all performed ICUS it has 
become an important indication. In more than 50% of those cases ICUS-diagnosis made 
the further clinical decision. 
1030-4 Discrepancy Between Morphologic and Functional 
Criteria of Optimal Stent Deployment Uslng 
Intravascular Ultrasound and Pressure Derived 
Myocardial Fractional Flow Reserve 
Hans, Andreas Kanig, Eva Drescher, Ulrike Buchmeier. Karl The&en, . 
Volkar Klauss, Med. Klinik -Innenstadt, Dept. of Cardiology. Munich, Germany. 
Background: Pressure derived myocardial fractional flow reserve (FFR), a functional 
index of epicardial stenosis might be useful for assessment of optimal stent deployment. 
The purpose of the study was to evaluate the diagnostic potential of serial FFR measure- 
ments in comparison to the ‘“gold standard’ intravascular ultrasound (IVUS) for optimal 
stent expansion using “Music criteria’. Methods: 30 patients (pts.; 9f, 21m, mean age: 
62*10 yrs.) with a single de nova lesion underwent PTCA followed by stent implantation 
(ACS Multi-Link Rx Duet) with an initial inflation pressure of 12 atm.. If optimal stent 
expansion criteria were not fulfilled, stent redilatation at 16 atm. was performed as well 
as additional balloon inflations with larger balloon sizes if necessary. P/US and FFR were 
performed after each dilatation (n=ll4). Results: Mean lumen area (2.9+1.3mm2) 
increased after PTCA and stent implantation (12atm.) to 7.6t2.lmmZ minimal stent area 
(MSA). Although adequate angiographic results (diameter stenosis < 10%) were 
obtained in 27 of 30 pts.,“Music criteria” were reached only in 9 pts.. FFR normalized 
from 0.60 to 0.93 (19 pts. > 0.94). Redilatation (16 atm.) increased MSA to 6.0*2.3mm2, 
which fulfilled optimal stent expansion in 27 pts. Mean MSA increased further to 
10.2+3.0mm2 using larger balloon sizes to fulfill IVUS inclusion criteria in all patients. 
Mean FFR increased slightly after stent implantation (16 atm and final: 0.96). Concfu- 
sions: FFR normalizes already after adequate angiographic stent implantation in approx- 
imately two thirds of pts. without reaching ‘Music criteria” in more than 50%. Therefore 
FFR does not predict optimal stent expansion according to IVUS criteria (positive ptedic- 
tive value 26%). 
1030-5 The Effect of Lesion Length on the Functional 
Significance of Coronary Lesions 
David Brash. Stuart T. Higano, Marvin J. Slepian, Hylton I. Miller, Morton J. Kern, David 
R. Holmes, Jr., Amir Lerman, Mayo Clinic Foundation, Rochester, Minnesota, Saint Louis 
University, Saint Louis, Missouri. 
Background: Fractional flow rese~e (FFR) has become the gold standard in physiologic 
assessment of coronary artery stenosis. This especially holds true for the functional eval- 
uation of angiographically intermediate lesions. A FFR value co.75 is considered a reli- 
able physiologic parameter indicating a functionally significant lesion. However, the effect 
of lesion length (LL) on FFR has not been adequately assessed. The current study was 
designed to study the effect of LL on FFR in patients with coronary artery disease. 
Methods: We performed FFR measurements by pressure guidewire, in 54 lesions (46 
pts.). LL and percent diameter stenosis (%DS) at the lesion site were determined by per- 
forming quantitative coronary angiography @CA) analysis. 
Results: Overall, there was a moderate inverse correlation between FFR and %DS (r=- 
0.55, p-zO.001). Using a receiver operating characteristic (ROC) curve analysis, a LL=lO 
mm was identified to be the best cutoff value for predicting a FFR=lOmm. as compared 
to LLclOmm (r-0.75, pcO.001; r=0.25, p=NS: respectively; Fig). Similar improvement 
with LL was ObSeNed for angiographically intermediate lesions (%DS: 50-70%; r=-0.73, 
p=lOmm: r=O.26, p=NS for LL-zlOmm). 
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Conclusions: This study demonstrates that Ll_ differentially effects the correlation 
between the functional assessment (FFR) and the “anatomical’ angiographic assess- 
ment (%DS) of coronary lesions and suggests that, l-l_ has a significant impact on the 
physiologic significance of coronary artery lesions. 
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0029-l Impact of Lesion Length on Vascular Brachytherapy 
Failure: A Comparison of Bets (b) versus Gamma (g) 
Irradiation In 99tl Patients 
BShirai, Alexandra J. Lansky, Roxana Mehran. Kartik Desai, Costantino 
Costantini-Ottiz, Brian Proctor, Teraza Conway, Martin Fahy, Maria Corral, Christina 
Brestowski, George Dangas, Gregg W. Stone, Paul Teirstein, Jeffrey Moses, Marlin B. 
Leon, Cardiovascular Research Foundation, New York. 
Background: Lesion length has been an important predictor of restenosis (RS) among 
pts treated with vascular brachytherapy (VET). Methods: We compared the impact of 
lesion length on RS in 990 pts treated with VBT (370 Gamma; 265 Beta; 355 placebo) for 
treatment of native coronary ISR. Results: Lesion length was an independent predictor of 
treated segment RS (OR=1.043, p~O.0001) but not stent edge RS (p=O.lZl). Regression 
analysis was used to construct probability models for ‘treated segment’ RS (including 
edges) (fig 1). ‘in-stent’ (fig 2) and “stent edge” (Fig 3) RS based on lesion lengths. A 
consistent pronounced treatment effect was observed with Gamma VBT at all lesion 
lengths. Beta VBT demonstrated the lowest probability of ‘“in-stent” RS at all lesion 
lengths. The divergent probability of ‘in-stent” and ‘treated segment” RS observed with 
beta radiation of focal lesions is a direct result of the higher frequency of stent edge RS 
as lesion length decreases. Conclusions: Mechanisms of edge RS differ for Beta and 
Gamma VBT. Edge RS appears to increase with increasing lesion length after Gamma 
VBT, possibly suggesting lack of adequate lesion coverage. With beta VBT, increasing 
edge RS among shorter lesions, may represent a proliferative response resulting from 
exposure of healthy arterial segments to VBT or to the steep dose fall-off zones. 
1:45 p.m. 
0029-2 Geographic Miss Is Not Associated With Restenosis or 
the Edge Phenomenon in the INHIBIT Trial 
0. Costantini, Alexandra J. Lansky, Kartik Desai, Roxana Mehran, Kazuyuki 
Shirai, Ecatarfna Cristea, Horia Marginean, George Dangas. Gregg W. Stone, Marlin B. 
Leon, Cardiovascular Research Foundation. New York. 
Background: “Geographic Miss” (GM) has been implicated as one impoltant cause 
explaining the preponderance of “edge” restenosis observed after vascular brschyther- 
apy. Methods: To determlne the impact of GM in INHIBIT, GM (length (mm) of balloon 
injuty beyond the proximal or distal radiated edges) was systematically measured in all 
patients using QCA (MEDIS). The probability of restenosis based on the length of GM 
was assessed for placebo and radiated pts using regression analysis, and the frequency 
of edge restenosis was compared among radiated patients with and without GM. 
Results: The frequency of GM (19.9% “s 15.3%, p&38) and the total length of GM 
(3.66mm vs 4.69mm, p=O.17) were similar in radiated and placebo pts respectively. The 
probability of restenosis for placebo and radiated pts was not affected by the presence or 
extent of GM and the relative benefit of P-32 radiation was maintained independent of 
GM (figure). Among radiated pts with GM (N=31) and without GM (N=125). there was no 
significant difference in restenosis (22.7% vs 25.7%, p=NS), proximal dose fall-off zone 
% stenosis (16% vs 21%. p=NS) or distal dose fall-off zone % stenosis (26% vs 23%. 
p=NS). Conclusion: In the INHIBIT trial, the presence and length of GM was not associ- 
ated with increases in overall restenosis for either radiated or placebo patients and the 
treatment effect of P-32 radiation was maintained despite the presence of GM. 
2:00 p.m. 
0029-3 Excessive Beta-Radiation Exposure to the Non-Target 
Segment: An Intravascular Ultrasound Doslmetric 
Analysis 
anedp. Yasuhiro Honda, Yoshihiro Merino, Atsushi Takagi, Ali H. Hassan, Tim 
Fox, Ian Crccker, Alexandra J. lansky, Paul G. Ycck, Raoul Bonan, Peter J. Fitzgerald, 
Stanford University, Stanford, California, Montreal Heart Institute, Montreal, Canada. 
Background: Recently, longer radioactive seed trains have been introduced into cathe- 
ter-based intracoronary brachytherapy to cover the entire target segment to avoid “geo- 
graphic miss’ and edge effects. This strategy, however, potentially leads to a higher 
radiation exposure to distal normal vasculature due to the natural tapering in distal core- 
nary arteries. The aim of this study was to evaluate the effect of beta-radiation on non- 
Injured distal segments using IVUS-based dosimetric analysis. 
Methods: We analyzed 16 instent restenosis cases (stent length: 20+6 mm) treated with 
a 40-mm scSrlY source train. The prescribed dose was 16 Gy (reference $3.35 mm) or 
20 Gy (reference > 3.35 mm) at 2 mm from the source. Non-injured but fully irradiated 
distal references were determined by angiography (average distance from stent edge: 
7.0 mm). Serial IVUS (baseline and 6-month follow-up (FU)) was performed with auto- 
mated pullback at 0.5 mm/s. Based upon the three-dtmensional vessel contours obtained 
at baseline, dose analysis was performed to calculate the minimum dose actually deliv- 
ered to 90% of plaque volume using a cumulative curve of dose-volume histogram 
(DVsc). Morphometric parameters (vessel, plaque, and lumen volumes) and DV, were 
computed in every 2.mm subsegment (n=49). Percent volume changes were calculated 
as (FU-baseline)/baseline. 
Results: There was a significant positive correlation between the delivered dose (DVs,,) 
and increase in plaque area during FU (p=O.O06). However, DVw also correlated posi- 
tively with change in vessel area (p=O.OOS), representing positive vessel remodeling fol- 
lowing beta-radiation. Consequently, no significant relationship was seen between DV,, 
and lumen change. 
Conclusions: Detailed IVUS-based dosimetric analysis demonstrated that beta-radia- 
tion promoted positive remodeling, preventing lumen loss despite an increase in plaque 
mass. The treatment of in-stent restenosis with long radioactive seed trains appeared to 
be safe with no deleterious effect on non-injured distal segments at the first 6 months. 
2:15 p.m. 
0029-4 lntracoronary Beta-Radiotherapy With 32P for the 
Prevention of Restenosls in Small Versus Large Vessels 
m Nauven - I HQ Pawel T. Zymek, Grzegorz L. Kaluza, Albert E. Raizner, for the 
PREVENT Investigators. The Methodist DeBakey Heart Center, Houston, Texas, Baylor 
Co//ege of Medicine, Houston, Texas. 
Background: Small vessel diameter (reference diameter ~3.0 mm) is predictive of rest- 
enosis in patients undergoing percutaneous coronary interventions. The Proliferation 
Reduction With Vascular Energy Trial (PREVENT) demonstrated that intracoronaly p- 
radiotherapy (ICR) with s*P is effective in inhibiting restenosis. We sought to determine 
the relative efficacy of ICR in vessels ~3.0 mm and 23.0 mm in 165 patients treated 
according to the PREVENT protocol. 
Methods and Results: The ICR-treated patients (11~125) were compared to sham- 
treated (control) patients (n=40) and analyzed according to the reference vessel diame- 
ter. The angiographic indices of restenosis are presented in the table (T=target site, 
T+A=target site plus adjacent edges: comparisons are ICR vs. control. ‘p<O.O03, 
“PCO.03). 
No. of patients 
Acute gain (mm) 
Late lumen loss (mm) 
Late loss index (%) 
Restenosis rate, T (%) 
c3.0 mm 23.0 mm 
ICR Control ICR Control 
46 21 77 19 
1.59fl.41 1.74*0.31 2.24i0.53 2.07iO.46 
0.22M.90 0.96fl.61 0.27*0.59* 1.05*0.76 
12*59 54+34 1 x29’ 5ti32 
18” 46 6’ 37 
Restenosis rate, T+A (%) 46 55 19 37 
